NCT02971215

Brief Summary

The purpose of this study is to assess the effectiveness of high intensity laser therapy in the treatment of subacromial impingement syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

November 15, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 22, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

November 8, 2017

Status Verified

March 1, 2017

Enrollment Period

8 months

First QC Date

November 15, 2016

Last Update Submit

November 6, 2017

Conditions

Outcome Measures

Primary Outcomes (12)

  • Shoulder Pain and Disability Index (SPADI)

    SPADI test

    Baseline

  • Shoulder Pain and Disability Index (SPADI)

    SPADI test

    At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)

  • Shoulder Pain and Disability Index (SPADI)

    SPADI test

    one month after the end of the protocol treatment

  • Shoulder Pain and Disability Index (SPADI)

    SPADI test

    three months after the end of the protocol treatment

  • Constant-Murley Score

    Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.

    Baseline

  • Constant-Murley Score

    Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.

    At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)

  • Constant-Murley Score

    Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.

    one month after the end of the protocol treatment

  • Constant-Murley Score

    Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.

    three months after the end of the protocol treatment

  • Quick-Dash Abbreviated

    Quick- Dash Abbreviated test

    Baseline

  • Quick-Dash Abbreviated

    Quick- Dash Abbreviated test

    At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)

  • Quick-Dash Abbreviated

    Quick- Dash Abbreviated test

    one month after the end of the protocol treatment

  • Quick-Dash Abbreviated

    Quick- Dash Abbreviated test

    three months after the end of the protocol treatment

Secondary Outcomes (3)

  • Painful pressure threshold

    Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment

  • Painful pressure threshold after first session

    First session - 15 minutes after laser or sham treatment.

  • VAS

    Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment

Other Outcomes (1)

  • Quality of life

    Baseline

Study Arms (2)

High-intensity laser therapy

EXPERIMENTAL

High-intensity laser therapy application through iLux Laser device

Device: iLux Laser

Sham device

SHAM COMPARATOR

Sham high-intensity laser therapy application through sham iLux Laser device

Device: Sham ilux Laser

Interventions

Treatment during 15 sessions. It is divided in two phases: 1. 12W. 50 Hz 20% duty cycle. 50 J/cm² in painful zone. 2. 15 W. Burst (10 pulses-900 msec each train) 250 J/cm² in painful zone. Trough the iLux Laser (Mectronic Medicale, Italy) \+ Physical Therapy protocol.

High-intensity laser therapy

Sham treatment during 15 sessions trough the iLux Laser (Mectronic Medicale, Italy), It is applies the same time than experimental one but with 0 W + Physical Therapy protocol.

Sham device

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 18 and 75 years old with diagnosis of subacromial impingement syndrome or any of the pathologies that compose it (tendinosis-tendinitis supraspinatus and rest of the rotator cuff, subacromial bursitis and tendinitis of the long head of the biceps).
  • Visual Analogue Scale (VAS) less than or equal to 7.
  • Forward flexion at least of 100º

You may not qualify if:

  • Calcific tendinitis
  • Complete rupture of the rotator cuff.
  • Adhesive capsulitis.
  • Clinical history of pathologies that without affecting the shoulder joint refer to painful shoulder symptoms (cervical root involvement, cervical surgery, cervical osteoarthritis and neurological pathologies)
  • Fibromyalgia
  • Be receiving physiotherapeutic treatment or have received it previously for this pathology one month before the start of treatment.
  • Patients with alterations of thermal sensitivity.
  • Derived from the absolute and relative contraindications of Laser Therapy:
  • Photosensitive patients
  • Neoplastic processes
  • Hyperthyroidism
  • Pregnancy
  • Patients with a history of epileptic seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital General Nuestra Señora del Prado

Talavera de la Reina, Toledo, 45600, Spain

Location

MeSH Terms

Conditions

Shoulder Impingement Syndrome

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and Injuries

Study Officials

  • Javier Aceituno-Gomez, PT

    Castilla-La Mancha Health Service

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2016

First Posted

November 22, 2016

Study Start

November 1, 2016

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

November 8, 2017

Record last verified: 2017-03

Locations